NCT01785615 Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin Status COMPLETED Phase PHASE1/PHASE2
NCT01784770 Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01783015 Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate Status TERMINATED Phase PHASE4
NCT01781572 A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT01781442 A Post Marketing Surveillance As Required By Philippine Food And Drug Administration Status WITHDRAWN Phase N/A
NCT01780987 AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients Status COMPLETED Phase PHASE3
NCT01776619 Safety and Tolerability Study of Multiple Doses of PF-06305591 Status COMPLETED Phase PHASE1
NCT01776437 Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers Status COMPLETED Phase PHASE1
NCT01775761 A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc) Status COMPLETED Phase PHASE1
NCT01775189 A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted Status COMPLETED Phase PHASE1
NCT01774721 ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC. Status COMPLETED Phase PHASE3
NCT01772329 Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects Status COMPLETED Phase NA
NCT01772264 Safety And Tolerability Study Of BID Titration Scheme With PF-05089771 Status COMPLETED Phase PHASE1
NCT01770964 Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy Status UNKNOWN Phase PHASE4
NCT01769274 Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia Status COMPLETED Phase PHASE2
NCT01768481 Intima Media Thickness Regression in Dyslipidemic Teenagers Status COMPLETED Phase PHASE3
NCT01768117 Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age Status COMPLETED Phase PHASE2
NCT01763164 Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Status COMPLETED Phase PHASE3
NCT01757756 Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects Status COMPLETED Phase PHASE1